Spectral Selling General Administrative vs Total Revenue Analysis

EDT Stock

CAD 0.53 0.03 6.00%

Spectral Med financial indicator trend analysis is much more than just breaking down Spectral Med prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Spectral Med is a good investment. Please check the relationship between Spectral Med Selling General Administrative and its Total Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative vs Total Revenue

Selling General Administrative vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Spectral Med Selling General Administrative account and Total Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between Spectral Med's Selling General Administrative and Total Revenue is 0.33. Overlapping area represents the amount of variation of Selling General Administrative that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Spectral Med, assuming nothing else is changed. The correlation between historical values of Spectral Med's Selling General Administrative and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Selling General Administrative of Spectral Med are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Selling General Administrative i.e., Spectral Med's Selling General Administrative and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.33

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Selling General Administrative

Total Revenue

Total revenue comprises all receipts Spectral Med generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Spectral Med's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Spectral Med current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Spectral Med's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 24th of November 2024, Enterprise Value is likely to grow to about 130.2 M, while Selling General Administrative is likely to drop about 8.1 M.

Spectral Med fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Non Currrent Assets Other	Inventory	Short Term Investments
Total Assets		-0.19	-0.27	-0.17	0.62	-0.44	-0.14	-0.75	0.35	0.52	0.91	0.08	0.99	0.02	-0.29	-0.06	0.08	0.66	-0.16	-0.12	1.0	0.69	-0.21	-0.22	0.08	0.55
Short Long Term Debt Total	-0.19		0.87	0.9	-0.84	0.37	0.64	0.76	-0.71	0.48	-0.06	0.36	-0.23	-0.2	0.6	0.92	0.2	-0.06	0.94	0.81	-0.22	-0.13	-0.23	-0.62	0.71	-0.18
Other Current Liab	-0.27	0.87		0.98	-0.83	0.44	0.56	0.69	-0.61	0.41	-0.08	0.08	-0.27	-0.42	0.52	0.79	0.25	-0.12	0.89	0.7	-0.27	-0.17	-0.24	-0.49	0.69	-0.24
Total Current Liabilities	-0.17	0.9	0.98		-0.82	0.45	0.6	0.65	-0.62	0.53	0.01	0.18	-0.18	-0.44	0.52	0.86	0.28	-0.1	0.94	0.74	-0.18	-0.11	-0.26	-0.58	0.76	-0.18
Total Stockholder Equity	0.62	-0.84	-0.83	-0.82		-0.66	-0.69	-0.91	0.79	-0.14	0.45	-0.32	0.65	0.31	-0.67	-0.81	-0.26	0.42	-0.87	-0.76	0.64	0.49	0.11	0.48	-0.59	0.46
Property Plant And Equipment Net	-0.44	0.37	0.44	0.45	-0.66		0.78	0.52	-0.57	-0.07	-0.29	0.49	-0.46	-0.58	0.48	0.54	0.45	-0.29	0.56	0.62	-0.47	-0.4	0.0	-0.6	0.53	-0.32
Current Deferred Revenue	-0.14	0.64	0.56	0.6	-0.69	0.78		0.51	-0.85	0.19	-0.03	0.72	-0.21	-0.25	0.81	0.8	0.32	-0.13	0.77	0.81	-0.19	-0.26	-0.44	-0.87	0.77	-0.38
Net Debt	-0.75	0.76	0.69	0.65	-0.91	0.52	0.51		-0.64	-0.01	-0.69	0.18	-0.77	-0.13	0.53	0.62	0.08	-0.43	0.69	0.58	-0.76	-0.37	0.01	-0.32	0.43	-0.31
Retained Earnings	0.35	-0.71	-0.61	-0.62	0.79	-0.57	-0.85	-0.64		-0.01	0.2	-0.53	0.42	-0.02	-0.97	-0.77	-0.11	0.26	-0.77	-0.78	0.39	0.47	0.57	0.57	-0.66	0.63
Accounts Payable	0.52	0.48	0.41	0.53	-0.14	-0.07	0.19	-0.01	-0.01		0.49	0.3	0.51	-0.29	-0.05	0.53	0.11	0.25	0.49	0.26	0.51	0.46	-0.17	-0.53	0.54	0.35
Cash	0.91	-0.06	-0.08	0.01	0.45	-0.29	-0.03	-0.69	0.2	0.49		0.11	0.91	-0.09	-0.15	0.08	0.15	0.59	0.0	0.04	0.91	0.41	-0.22	-0.22	0.17	0.29
Non Current Assets Total	0.08	0.36	0.08	0.18	-0.32	0.49	0.72	0.18	-0.53	0.3	0.11		0.0	-0.02	0.51	0.55	0.08	-0.15	0.43	0.54	0.01	-0.22	-0.29	-0.71	0.48	-0.3
Cash And Short Term Investments	0.99	-0.23	-0.27	-0.18	0.65	-0.46	-0.21	-0.77	0.42	0.51	0.91	0.0		-0.03	-0.36	-0.11	0.08	0.67	-0.2	-0.17	1.0	0.72	-0.17	-0.16	0.04	0.59
Net Receivables	0.02	-0.2	-0.42	-0.44	0.31	-0.58	-0.25	-0.13	-0.02	-0.29	-0.09	-0.02	-0.03		0.15	-0.33	-0.65	-0.01	-0.39	-0.36	0.02	-0.07	-0.33	0.37	-0.28	-0.25
Common Stock Shares Outstanding	-0.29	0.6	0.52	0.52	-0.67	0.48	0.81	0.53	-0.97	-0.05	-0.15	0.51	-0.36	0.15		0.66	-0.04	-0.24	0.66	0.67	-0.33	-0.42	-0.71	-0.51	0.64	-0.66
Non Current Liabilities Total	-0.06	0.92	0.79	0.86	-0.81	0.54	0.8	0.62	-0.77	0.53	0.08	0.55	-0.11	-0.33	0.66		0.39	-0.06	0.98	0.9	-0.1	-0.13	-0.28	-0.78	0.81	-0.18
Other Current Assets	0.08	0.2	0.25	0.28	-0.26	0.45	0.32	0.08	-0.11	0.11	0.15	0.08	0.08	-0.65	-0.04	0.39		0.1	0.37	0.57	0.08	-0.01	0.4	-0.36	0.15	0.24
Other Stockholder Equity	0.66	-0.06	-0.12	-0.1	0.42	-0.29	-0.13	-0.43	0.26	0.25	0.59	-0.15	0.67	-0.01	-0.24	-0.06	0.1		-0.11	-0.13	0.68	0.58	-0.04	-0.11	0.06	0.51
Total Liab	-0.16	0.94	0.89	0.94	-0.87	0.56	0.77	0.69	-0.77	0.49	0.0	0.43	-0.2	-0.39	0.66	0.98	0.37	-0.11		0.88	-0.19	-0.17	-0.26	-0.72	0.8	-0.23
Property Plant And Equipment Gross	-0.12	0.81	0.7	0.74	-0.76	0.62	0.81	0.58	-0.78	0.26	0.04	0.54	-0.17	-0.36	0.67	0.9	0.57	-0.13	0.88		-0.16	-0.23	-0.2	-0.72	0.67	-0.22
Total Current Assets	1.0	-0.22	-0.27	-0.18	0.64	-0.47	-0.19	-0.76	0.39	0.51	0.91	0.01	1.0	0.02	-0.33	-0.1	0.08	0.68	-0.19	-0.16		0.71	-0.19	-0.17	0.05	0.57
Short Term Debt	0.69	-0.13	-0.17	-0.11	0.49	-0.4	-0.26	-0.37	0.47	0.46	0.41	-0.22	0.72	-0.07	-0.42	-0.13	-0.01	0.58	-0.17	-0.23	0.71		-0.05	-0.19	0.1	0.9
Intangible Assets	-0.21	-0.23	-0.24	-0.26	0.11	0.0	-0.44	0.01	0.57	-0.17	-0.22	-0.29	-0.17	-0.33	-0.71	-0.28	0.4	-0.04	-0.26	-0.2	-0.19	-0.05		0.34	-0.56	0.38
Non Currrent Assets Other	-0.22	-0.62	-0.49	-0.58	0.48	-0.6	-0.87	-0.32	0.57	-0.53	-0.22	-0.71	-0.16	0.37	-0.51	-0.78	-0.36	-0.11	-0.72	-0.72	-0.17	-0.19	0.34		-0.79	-0.07
Inventory	0.08	0.71	0.69	0.76	-0.59	0.53	0.77	0.43	-0.66	0.54	0.17	0.48	0.04	-0.28	0.64	0.81	0.15	0.06	0.8	0.67	0.05	0.1	-0.56	-0.79		-0.12
Short Term Investments	0.55	-0.18	-0.24	-0.18	0.46	-0.32	-0.38	-0.31	0.63	0.35	0.29	-0.3	0.59	-0.25	-0.66	-0.18	0.24	0.51	-0.23	-0.22	0.57	0.9	0.38	-0.07	-0.12

Click cells to compare fundamentals

Spectral Med Account Relationship Matchups

Spectral Med fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.0M	8.2M	11.6M	12.0M	5.2M	5.0M
Other Current Liab	704K	980K	1.1M	1.5M	7.5M	7.9M
Total Current Liabilities	1.1M	2.9M	2.3M	4.0M	10.2M	10.8M
Total Stockholder Equity	2.3M	(669K)	4.1M	(2.5M)	(16.5M)	(15.7M)
Property Plant And Equipment Net	1.1M	1.1M	1.1M	701K	893K	1.2M
Net Debt	(691K)	(5.1M)	(8.3M)	(1.8M)	5.6M	5.9M
Retained Earnings	(80.6M)	(89.7M)	(98.5M)	(109.7M)	(125.4M)	(119.2M)
Accounts Payable	298K	1.2M	444K	1.7M	1.6M	1.2M
Cash	1.4M	5.8M	8.9M	8.4M	3.0M	5.8M
Non Current Assets Total	1.4M	1.4M	1.3M	1.9M	1.1M	1.0M
Cash And Short Term Investments	1.4M	5.8M	8.9M	8.4M	3.0M	2.8M
Net Receivables	790K	260K	205K	1.1M	186K	176.7K
Common Stock Shares Outstanding	225.7M	232.5M	252.5M	269.8M	278.6M	292.5M
Liabilities And Stockholders Equity	4.0M	8.2M	11.6M	12.0M	5.2M	5.0M
Non Current Liabilities Total	667K	5.9M	5.2M	10.6M	11.5M	12.1M
Other Current Assets	155K	389K	875K	276K	621K	404.4K
Total Liab	1.7M	8.8M	7.5M	14.5M	21.8M	22.8M
Property Plant And Equipment Gross	1.1M	1.1M	4.2M	3.8M	4.2M	4.4M
Total Current Assets	2.7M	6.8M	10.3M	10.1M	4.1M	3.9M
Accumulated Other Comprehensive Income	8.1M	9.2M	10.2M	11.4M	12.9M	13.6M
Short Term Debt	77K	85K	92K	96K	385K	365.8K
Intangible Assets	263K	246K	228K	211K	193K	183.4K
Non Currrent Assets Other	(1.4M)	(1.4M)	(1.3M)	(1.9M)	(1.7M)	(1.6M)
Inventory	276K	348K	293K	340K	366K	474.6K
Short Term Investments	64K	232K	717K	241K	608K	577.6K
Common Stock Total Equity	63.2M	66.6M	66.8M	71.9M	82.7M	60.2M
Common Stock	66.8M	71.9M	84.4M	87.1M	87.1M	68.9M
Net Tangible Assets	2.0M	(915K)	3.9M	(2.7M)	(2.5M)	(2.3M)
Property Plant Equipment	1.1M	1.1M	1.1M	701K	806.2K	807.7K
Long Term Debt Total	667K	582K	490K	6.5M	7.5M	7.9M
Net Invested Capital	2.3M	(669K)	4.1M	3.6M	(8.6M)	(8.2M)
Net Working Capital	1.6M	3.9M	8.0M	6.1M	(6.1M)	(5.8M)
Capital Stock	66.8M	71.9M	84.4M	87.1M	87.1M	85.0M

Pair Trading with Spectral Med

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.

Moving against Spectral Stock

0.85	WMT	Walmart Inc CDR	Pair Corr
0.77	META	Meta Platforms CDR	Pair Corr
0.75	TSLA	Tesla Inc CDR	Pair Corr
0.73	AMZN	Amazon CDR	Pair Corr
0.71	NVDA	NVIDIA CDR	Pair Corr

The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.

The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Spectral Stock

Balance Sheet is a snapshot of the financial position of Spectral Med at a specified time, usually calculated after every quarter, six months, or one year. Spectral Med Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Spectral Med and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Spectral currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Spectral Selling General Administrative vs Total Revenue Analysis

Selling General Administrative vs Total Revenue

Selling General Administrative vs Total Revenue Correlation Analysis

Correlation Coefficient

Selling General Administrative

Total Revenue

Spectral Med fundamental ratios Correlations

Spectral Med Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Spectral Med fundamental ratios Accounts

Pair Trading with Spectral Med

Moving against Spectral Stock

Other Information on Investing in Spectral Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Liabilities	+ 0.98	Other Current Liab
Total Liab	+ 0.98	Non Current Liabilities Total
Total Liab	+ 0.94	Short Long Term Debt Total

Common Stock Shares Outstanding	- 0.97	Retained Earnings
Net Debt	- 0.91	Total Stockholder Equity
Non Currrent Assets Other	- 0.87	Current Deferred Revenue
Total Liab	- 0.87	Total Stockholder Equity
Retained Earnings	- 0.85	Current Deferred Revenue
Total Stockholder Equity	- 0.84	Short Long Term Debt Total